CH415633A - Verfahren zur Herstellung von Aminosäuren - Google Patents

Verfahren zur Herstellung von Aminosäuren

Info

Publication number: CH415633A
Authority: CH; Switzerland
Prior art keywords: acid; ester; oxy; amino; hydrogen
Prior art date: 1960-08-19

Application number

CH966261A

Other languages

German (de)

English (en)

Inventor

Sletzinger Meyer

Pfister Karl

Floyd Reinhold Donald

Original Assignee

Merck & Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1960-08-19

Filing date

1961-08-18

Publication date

1966-06-30

1961-08-18 Application filed by Merck & Co Inc filed Critical Merck & Co Inc

1966-06-30 Publication of CH415633A publication Critical patent/CH415633A/de

Links

238000000034 method Methods 0.000 title claims description 12
150000001413 amino acids Chemical class 0.000 title claims description 8
238000004519 manufacturing process Methods 0.000 title claims description 3
150000002148 esters Chemical class 0.000 claims description 18
125000000217 alkyl group Chemical group 0.000 claims description 14
239000002253 acid Substances 0.000 claims description 13
150000001875 compounds Chemical class 0.000 claims description 11
229910052739 hydrogen Inorganic materials 0.000 claims description 11
239000001257 hydrogen Substances 0.000 claims description 11
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 9
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 7
239000003054 catalyst Substances 0.000 claims description 7
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
125000001931 aliphatic group Chemical group 0.000 claims description 6
150000001412 amines Chemical class 0.000 claims description 5
238000005984 hydrogenation reaction Methods 0.000 claims description 5
239000011541 reaction mixture Substances 0.000 claims description 5
NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 claims description 4
229910000564 Raney nickel Inorganic materials 0.000 claims description 4
239000007868 Raney catalyst Substances 0.000 claims description 3
239000003513 alkali Substances 0.000 claims description 3
238000010438 heat treatment Methods 0.000 claims description 3
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
239000002904 solvent Substances 0.000 claims description 3
239000003849 aromatic solvent Substances 0.000 claims description 2
150000002828 nitro derivatives Chemical class 0.000 claims description 2
229910052500 inorganic mineral Inorganic materials 0.000 claims 1
239000011707 mineral Substances 0.000 claims 1
XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 18
-1 nitro-oxylindolyl-propionic acid Chemical compound 0.000 description 16
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
235000019260 propionic acid Nutrition 0.000 description 10
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 7
235000014113 dietary fatty acids Nutrition 0.000 description 7
229930195729 fatty acid Natural products 0.000 description 7
239000000194 fatty acid Substances 0.000 description 7
229910052757 nitrogen Inorganic materials 0.000 description 7
KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 7
239000000047 product Substances 0.000 description 7
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 7
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
125000005907 alkyl ester group Chemical group 0.000 description 5
235000001014 amino acid Nutrition 0.000 description 5
239000000203 mixture Substances 0.000 description 5
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
239000007795 chemical reaction product Substances 0.000 description 4
125000004494 ethyl ester group Chemical group 0.000 description 4
150000004665 fatty acids Chemical class 0.000 description 4
229910052763 palladium Inorganic materials 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
150000003839 salts Chemical class 0.000 description 4
SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 3
210000004556 brain Anatomy 0.000 description 3
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
229960002748 norepinephrine Drugs 0.000 description 3
SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 3
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
241000124008 Mammalia Species 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
230000010933 acylation Effects 0.000 description 2
238000005917 acylation reaction Methods 0.000 description 2
YHASWHZGWUONAO-UHFFFAOYSA-N butanoyl butanoate Chemical compound CCCC(=O)OC(=O)CCC YHASWHZGWUONAO-UHFFFAOYSA-N 0.000 description 2
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
238000001816 cooling Methods 0.000 description 2
230000000694 effects Effects 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
239000005457 ice water Substances 0.000 description 2
231100000252 nontoxic Toxicity 0.000 description 2
230000003000 nontoxic effect Effects 0.000 description 2
125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 2
239000002244 precipitate Substances 0.000 description 2
150000004672 propanoic acids Chemical class 0.000 description 2
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
238000010992 reflux Methods 0.000 description 2
239000007858 starting material Substances 0.000 description 2
238000003860 storage Methods 0.000 description 2
229940005605 valeric acid Drugs 0.000 description 2
BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
KSYBRTXOXKWUIR-UHFFFAOYSA-N 2-nitrobutanoic acid Chemical compound CCC(C(O)=O)[N+]([O-])=O KSYBRTXOXKWUIR-UHFFFAOYSA-N 0.000 description 1
ZOQUFUUTAALPJD-UHFFFAOYSA-N 2-nitropentanoic acid Chemical compound CCCC(C(O)=O)[N+]([O-])=O ZOQUFUUTAALPJD-UHFFFAOYSA-N 0.000 description 1
PTYVBEKOPJHZLJ-UHFFFAOYSA-N 2-nitropropanoic acid Chemical compound OC(=O)C(C)[N+]([O-])=O PTYVBEKOPJHZLJ-UHFFFAOYSA-N 0.000 description 1
GOLXRNDWAUTYKT-UHFFFAOYSA-N 3-(1H-indol-3-yl)propanoic acid Chemical compound C1=CC=C2C(CCC(=O)O)=CNC2=C1 GOLXRNDWAUTYKT-UHFFFAOYSA-N 0.000 description 1
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1
FNKKANADPBOGGN-UHFFFAOYSA-N C1=CC=C2NC([N])=CC2=C1 Chemical compound C1=CC=C2NC([N])=CC2=C1 FNKKANADPBOGGN-UHFFFAOYSA-N 0.000 description 1
MVXINDOXMXOCPT-UHFFFAOYSA-N CCCC(C(OCC1=CC=CC=C1)=O)[N+]([O-])=O Chemical compound CCCC(C(OCC1=CC=CC=C1)=O)[N+]([O-])=O MVXINDOXMXOCPT-UHFFFAOYSA-N 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
NQPDZGIKBAWPEJ-UHFFFAOYSA-N Valeric acid Natural products CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
ORWKVZNEPHTCQE-UHFFFAOYSA-N acetic formic anhydride Chemical compound CC(=O)OC=O ORWKVZNEPHTCQE-UHFFFAOYSA-N 0.000 description 1
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
230000021736 acetylation Effects 0.000 description 1
238000006640 acetylation reaction Methods 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
150000001294 alanine derivatives Chemical class 0.000 description 1
230000002152 alkylating effect Effects 0.000 description 1
239000000908 ammonium hydroxide Substances 0.000 description 1
230000003276 anti-hypertensive effect Effects 0.000 description 1
239000002220 antihypertensive agent Substances 0.000 description 1
229940030600 antihypertensive agent Drugs 0.000 description 1
125000003710 aryl alkyl group Chemical group 0.000 description 1
125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
239000003245 coal Substances 0.000 description 1
MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical compound C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 1
230000032050 esterification Effects 0.000 description 1
238000005886 esterification reaction Methods 0.000 description 1
238000009472 formulation Methods 0.000 description 1
125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
150000002431 hydrogen Chemical class 0.000 description 1
IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
229910000041 hydrogen chloride Inorganic materials 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
239000012442 inert solvent Substances 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
230000002045 lasting effect Effects 0.000 description 1
POTVAILTNPOQJH-UHFFFAOYSA-N n,n-dimethyl-1-(5-phenylmethoxy-1h-indol-3-yl)methanamine Chemical compound C1=C2C(CN(C)C)=CNC2=CC=C1OCC1=CC=CC=C1 POTVAILTNPOQJH-UHFFFAOYSA-N 0.000 description 1
FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
239000012044 organic layer Substances 0.000 description 1
239000003208 petroleum Substances 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
230000001376 precipitating effect Effects 0.000 description 1
WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
150000003254 radicals Chemical class 0.000 description 1
239000000376 reactant Substances 0.000 description 1
238000001953 recrystallisation Methods 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
239000000725 suspension Substances 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
239000008096 xylene Substances 0.000 description 1

Landscapes

Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

CH966261A 1960-08-19 1961-08-18 Verfahren zur Herstellung von Aminosäuren CH415633A (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US5058260A	1960-08-19	1960-08-19

Publications (1)

Publication Number	Publication Date
CH415633A true CH415633A (de)	1966-06-30

Family

ID=21966099

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CH966261A CH415633A (de)	1960-08-19	1961-08-18	Verfahren zur Herstellung von Aminosäuren

Country Status (3)

Country	Link
BE (1)	BE607172A (es)
CH (1)	CH415633A (es)
ES (1)	ES270385A1 (es)

1961
- 1961-08-11 BE BE607172A patent/BE607172A/fr unknown
- 1961-08-18 CH CH966261A patent/CH415633A/de unknown
- 1961-08-18 ES ES270385A patent/ES270385A1/es not_active Expired

Also Published As

Publication number	Publication date
ES270385A1 (es)	1962-02-16
BE607172A (fr)	1962-02-12

Publication	Publication Date	Title
DE1518002C3 (de)	1975-01-23	Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel
DE1645971A1 (de)	1970-07-16	Verfahren zur Herstellung von therapeutisch wertvollen (Indazol-3-yl)-oxyalkansaeuren
DE2046904A1 (de)	1971-04-22	Indohzinessigsauren und Verfahren zu ihrer Herstellung
DE2854341C2 (es)	1990-05-23
DE1795424C3 (de)	1973-09-20	Glucuronsaureester von 1 Acyl 2 methyl 5 methoxy 3 lndolylessigsauren
AT234104B (de)	1964-06-10	Verfahren zur Herstellung von neuen Indolylderivaten sowie von deren Säuresalzen
DE1593834A1 (de)	1971-02-25	Verfahren zur Herstellung von therapeutisch wirksamen Acylaminophenolalkanolen
DE1693026C3 (de)	1976-06-24	Antibiotisch wirkende Delta hoch 13(17) - und Delta hoch 13(17);20(22) - Fusidinsäurederivate und Verfahren zu ihrer Herstellung
CH449006A (de)	1967-12-31	Verfahren zur Herstellung von Fusidinsäure- und Dihydrofusidinsäurederivaten
DE1202277B (de)	1965-10-07	Verfahren zur Herstellung neuer Ester des (Piperidyl-2)-phenyl-carbinols
DE963776C (de)	1957-05-16	Verfahren zur Herstellung von antiphlogistisch wirksamen ª‡-Amino-ª‰-oxycarbonsaeureaniliden
AT215417B (de)	1961-06-12	Verfahren zur Herstellung neuer N-Carbalkoxy- bzw. -aralkoxyalkyl-β-(3,4-dihydroxyphenyl)-β-hydroxyäthylamine und deren Salze
DE1958383A1 (de)	1970-06-04	Leupeptine und ihre Analoga
DE842051C (de)	1952-06-23	Verfahren zur Herstellung von Hydrofluoren-2-carbonsaeuren und ihren Derivaten
DE1804392A1 (de)	1969-05-22	9-0-Kalamycinderivate und Verfahren zu ihrer Herstellung
DE901415C (de)	1954-01-11	Verfahren zur Herstellung von í¸-Androstadienol-(17)-on-(3) bzw. seiner funktionellen Derivate der Hydroxylgruppe
AT269886B (de)	1969-04-10	Verfahren zur Herstellung neuer Benzomorphanderivate und ihrer Salze
DE1493917C (de)	1973-03-01	Phenylalkanolaminderivate und Verfahren zu deren Herstellung
CH333721A (de)	1958-10-31	Verfahren zur Herstellung von Diestern der Morphinreihe
DE2329815C3 (de)	1976-10-07	Pharmazeutisches Mittel zur Behandlung von Atherosklerose, Thrombose und Hämorrhagie
DE1445697C (de)		Verfahren zur Herstellung von Piperidincarbonsäureestern
DE1801312C (de)	1972-09-14	2 (4 Biphenylyloxy)-heptansaure, ihre Alkali und Erdalkahsalze und diese Verbin düngen enthaltene Arzneimittel
DE1200832B (de)	1965-09-16	Verfahren zur Herstellung von 3, 5-Dijodthyroninderivaten
DE1967030B2 (de)	1977-11-24	Gamma-lactame der 6h,7h-cis-7- amino-3-aminomethyl-ceph-3-em-4-carbonsaeuren
DE1917036C3 (de)	1976-12-16	N-Acyl-N-(substituiertes)phenyl-4amino-buttersäuren und deren Salze, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel